Electra Therapeutics, Inc. (ETRA) Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Medical - Pharmaceuticals
Electra Therapeutics Inc. NASDAQ:ETRA Healthcare · Medical - Pharmaceuticals
Mkt Cap $508.41M
Vol 0
$ Vol 0
RVOL 0
Earnings 0
8-K S-1 S-1/A S-8 3 4 13D 13G 424B4 D
Form Description Filed Links 13G Beneficial Ownership Report
10/29/26 Oct 29, 2026 13G Beneficial Ownership Report
9/28/26 Sep 28, 2026 13G Beneficial Ownership Report
9/28/26 Sep 28, 2026 13D 9/25/26 Sep 25, 2026 4 Statement of Changes in Beneficial Ownership
9/23/26 Sep 23, 2026 4 Statement of Changes in Beneficial Ownership
9/23/26 Sep 23, 2026 3 9/21/26 Sep 21, 2026 4 Statement of Changes in Beneficial Ownership
9/21/26 Sep 21, 2026 4 Statement of Changes in Beneficial Ownership
9/21/26 Sep 21, 2026 4 Statement of Changes in Beneficial Ownership
9/21/26 Sep 21, 2026 4 Statement of Changes in Beneficial Ownership
9/21/26 Sep 21, 2026 S-8 9/21/26 Sep 21, 2026 8-K 9/21/26 Sep 21, 2026 424B4 9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026 3 Initial Statement of Beneficial Ownership
9/18/26 Sep 18, 2026
